Persistence of a t(11;14)-positive clone in a patient with mantle cell lymphoma for 20 years.

Yasuyuki OtsukaMomoko NishikoriToshiyuki KitanoTomomi OkaTakayuki IshikawaHironori HagaAkifumi Takaori-Kondo

Published in: Clinical case reports (2017)

We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non-nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases.

Keyphrases

end stage renal disease
case report
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
squamous cell carcinoma
patient reported
rectal cancer